JAN 31, 2017 6:06 AM PST

Mapping Serotonin Dynamics in the Brain

Serotonin is pretty well known as far as brain chemicals go. It’s a neurotransmitter which means it’s part of the communication process that happens between neurons in the brain. What many might not know is that 80-90% of the serotonin in the body is produced in the intestinal tract. The rest is produced in the brain. What is used in the brain must be produced there. There are volumes of research that show that serotonin is important for mood balance and feelings of well-being. This is why many psychiatric medications to treat depression are designed to interact with serotonin. SSRI medications block the neurotransmitter from being reabsorbed in the brain, so more is available to as a mood stabilizer. One of the challenges to monitoring and trying to regulate serotonin has been that the mechanics of it were not easily seen by imaging or other testing.

New research from MIT might be the first step in changing that and hopefully learning more about the dynamics of the serotonin supply in the brain. The work recently completed by the MIT team has shown for the first time, in 3D no less, a real time map of serotonin making its way around the brain. Aviad Hai, a postdoc in the Department of Biological Engineering and first author of the paper describing the technique stated,  “Until now, it was not possible to look at how neurotransmitters are transported into cells across large regions of the brain. It’s the first time you can see the inhibitors of serotonin reuptake, like antidepressants, working in different parts of the brain, and you can use this information to analyze all sorts of antidepressant drugs, discover new ones, and see how those drugs affect the serotonin system across the brain.”

Before this research, the only way to really know how serotonin was moving through brain tissue was a by literally poking a probe into the brain and taking tiny chemical samples from the tissue. Hardly something most patients want to go through. The method the MIT researchers came up involved creating a protein that would chemically bond to serotonin as it traveled through the brain. Using this as a sensor, the team was able to map where it went. Once serotonin was reabsorbed, the sensing protein would detach. This protein would also emit a signal and when injected into the brain, along with serotonin. That signal could be picked up and imaged by a functional MRI scan. The signal only fired when the protein was detached from the serotonin. The MRI images contained pixels, which were then converted to voxels (which are pixels in 3D) using a mathematical model. Over 1,000 voxels were detected in the work, and the model was used to create a 3D map of the where, when and how the serotonin was moving and being absorbed.

The team used this method to successfully measure the effect that would be expected when the SSRI fluoxetine (Prozac) was used. Their mapping and math was successful in illustrating the decrease in serotonin reuptake that is known to happen when Prozac is used to treat depression. They also unexpectedly discovered that a dopamine transport reuptake inhibitor used in one of the experiments also reduced serotonin reuptake, further validating the suspected connection between the role of both dopamine and serotonin in mental illness.

While drugs like Prozac only target serotonin, Hai explained that targeting more than one neurotransmitter might be a better way to treat depression. “It may not be sufficient to just block serotonin reuptake, because there’s another system — dopamine — that plays a role in serotonin transport as well. It’s almost proof that when you use antidepressants that … target both systems, it could be more effective,” he said. The video talks more about this significant development in mapping brain activity, take a look.

Sources: MIT, MDJunction.com, Neuron, UPI

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
NOV 17, 2019
Neuroscience
NOV 17, 2019
Intelligence, Not Mindset, Predicts Learning Ability
New research has found that intelligence may play more of a role in a person’s ability to learn to play the piano than believing in oneself or having...
DEC 01, 2019
Neuroscience
DEC 01, 2019
Are teens addicted to their phones?
Journalists quickly jumped to the conclusion that 23% of teenagers are addicted to their smartphones thanks to findings from a new study from King’s ...
DEC 09, 2019
Cell & Molecular Biology
DEC 09, 2019
Newly IDed Biomarker Can Predict Compulsive Drinking
Lots of people drink alcohol, but not everyone develops a drinking problem. Researchers are starting to learn more about why that is....
DEC 19, 2019
Drug Discovery & Development
DEC 19, 2019
Upcoming Psychedelic Cure for Addiction Derived from African Shrub
Every year, almost 70,000 people die from an overdose in the US. Now, a company called MindMed is testing a compound derived from ibogaine, a West African ...
JAN 16, 2020
Neuroscience
JAN 16, 2020
Early-life Stress and Pollution Lead to Cognitive Impairment
Children exposed to high levels of stress at home from early on and high levels of air pollution while still in the womb are more likely to develop attenti...
FEB 26, 2020
Neuroscience
FEB 26, 2020
Why Alzheimer's may be a Sleep Disorder
Alzheimer’s disease is a form of dementia in which amyloid-beta protein builds up in the brain, killing off surrounding neurons and causing cognitive...
Loading Comments...